Earnings Feed
Start Free
Home/Filings/4/0000899243-17-028061
4//SEC Filing

Molineaux Christopher 4

Accession 0000899243-17-028061

CIK 0001496671other
View on SEC.govCompany Profile

Filed

Dec 5, 7:00 PM ET

Accepted

Dec 6, 4:05 PM ET

Size

17.5 KB

Accession

0000899243-17-028061

Insider Transaction Report

Form 4
Period: 2017-12-05
Calithera Biosciences, Inc.CALA
Molineaux Christopher
SR. VP, DEVELOPMENT
Transactions
  • Exercise/Conversion

    Common Stock

    2017-12-05$0.96/sh+6,502$6,242→ 9,002 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2017-12-05−2,700→ 6,006 total
    Exercise: $2.64Exp: 2023-12-16→ Common Stock (2,700 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2017-12-05−5,300→ 34,030 total(indirect: By Spouse)
    Exercise: $2.64Exp: 2023-12-16→ Common Stock (5,300 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2017-12-05−6,502→ 0 total
    Exercise: $0.96Exp: 2023-05-22→ Common Stock (6,502 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2017-12-05−7,568→ 0 total(indirect: By Spouse)
    Exercise: $0.96Exp: 2023-05-22→ Common Stock (7,568 underlying)
  • Exercise/Conversion

    Common Stock

    2017-12-05$2.64/sh+2,700$7,128→ 11,702 total
Holdings

  • Common Stock

    (indirect: By Trust)
    349,190

  • Common Stock

    (indirect: By Spouse)
    15,368
Footnotes (4)
  • [F1]Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on June 9, 2017.
  • [F2]Shares are held by the Molineaux Family Trust, of which the Reporting Person is a Trustee, including 12,044 shares transferred from the Reporting Person to the Molineaux Family Trust on March 30, 2017.
  • [F3]1/48 of the Option vests in equal monthly installments one month from 05/23/2013. The option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.
  • [F4]1/48 of the Option vests in equal monthly installments one month from 12/17/2013. The option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.

Documents

1 file

Issuer

Calithera Biosciences, Inc.

CIK 0001496671

→
Entity typeother

Related Parties

1
  • filerCIK 0001618120

Filing Metadata

Form type
4
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 4:05 PM ET
Size
17.5 KB
View on SEC.gov